Singapore investing billions more into biomedical R&D

Impatient to see a big payback in new jobs and companies in return for its huge investment in biomedical R&D, Singapore is setting up a $1 billion fund to help promote ties between the science and technology industries. Singapore is preparing to sink another $12 billion into R&D between 2011 and 2015. The city-state is upping the amount of money devoted to achieving economic success from 65 percent of its funds to 70 percent. Story

Suggested Articles

Outgoing BIO Chair John Maraganore and his successor, Jeremy Levin, reflected on drug pricing, its drivers and its place in the innovation ecosystem.

The study is assessing the effect of the oral AXL inhibitor when given to elderly AML patients in combination with low-intensity chemotherapy.

The proportion of patients who had a greater than 1 g/dL increase in hemoglobin is down on GBT’s prior update but still superior to placebo.